triphosphoric acid has been researched along with encorafenib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, AN; Augustyn, K; Joseph, J; Patel, AB; Razmandi, A; Tawbi, HA | 1 |
1 other study(ies) available for triphosphoric acid and encorafenib
| Article | Year |
|---|---|
Treatment experience with encorafenib plus binimetinib for BRAF V600-mutant metastatic melanoma: management insights for clinical practice.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Melanoma; Mitogen-Activated Protein Kinase Kinases; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms | 2023 |